Control of adenovirus acute respiratory disease in U.S. Army trainees.
Although limited almost exclusively to military trainees, acute respiratory disease (ARD) caused by adenovirus types 4 and 7 had been the leading cause of hospitalization in U.S. Army personnel. This decrease which resembles influenza in clinical manifestations led to hospitalization of as many as 50% of military trainees in midwinter and imposed a heavy burden on military hospitals and training programs. In studies undertaken from 1965 to 1970, live adenovirus type 4 and subsequently type 7 vaccines were found to be safe and immunogenic and to confer protection against type specific adenovirus ARD. For the past 5 yr. military trainees have been immunized with both adenovirus vaccines during periods of expected adenovirus disease. Since 1966, use of adenovirus vaccines has been monitored through the adenovirus surveillance program which yields weekly data on incidence and etiology of ARD in basic combat trainees. Since 1973, stable adenovirus vaccines have resulted in excellent control of adenovirus ARD. Potential problems with this immunization program are discussed.
D000256:Adenoviridae / Q000302:isolation & purification; D000260:Adenoviruses, Human / Q000302:isolation & purification; D000917:Antibody Formation; D000918:Antibody Specificity; D006801:Humans; D007114:Immunization; D007115:Immunization Schedule; D008297:Male; D008887:Military Medicine; D012140:Respiratory Tract Diseases / Q000276:immunology / Q000517:prevention & control*; D014481:United States; D014612:Vaccines / Q000592:standards
D014612:Vaccines